Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
FDF
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
ABOUT THIS PAGE
A Pemigatinib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Pemigatinib, including repackagers and relabelers. The FDA regulates Pemigatinib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Pemigatinib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Pemigatinib manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Pemigatinib supplier is an individual or a company that provides Pemigatinib active pharmaceutical ingredient (API) or Pemigatinib finished formulations upon request. The Pemigatinib suppliers may include Pemigatinib API manufacturers, exporters, distributors and traders.
click here to find a list of Pemigatinib suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Pemigatinib DMF (Drug Master File) is a document detailing the whole manufacturing process of Pemigatinib active pharmaceutical ingredient (API) in detail. Different forms of Pemigatinib DMFs exist exist since differing nations have different regulations, such as Pemigatinib USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Pemigatinib DMF submitted to regulatory agencies in the US is known as a USDMF. Pemigatinib USDMF includes data on Pemigatinib's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Pemigatinib USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Pemigatinib suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Pemigatinib as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Pemigatinib API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Pemigatinib as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Pemigatinib and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Pemigatinib NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Pemigatinib suppliers with NDC on PharmaCompass.
Pemigatinib Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Pemigatinib GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Pemigatinib GMP manufacturer or Pemigatinib GMP API supplier for your needs.
A Pemigatinib CoA (Certificate of Analysis) is a formal document that attests to Pemigatinib's compliance with Pemigatinib specifications and serves as a tool for batch-level quality control.
Pemigatinib CoA mostly includes findings from lab analyses of a specific batch. For each Pemigatinib CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Pemigatinib may be tested according to a variety of international standards, such as European Pharmacopoeia (Pemigatinib EP), Pemigatinib JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Pemigatinib USP).
LOOKING FOR A SUPPLIER?
